Structure‐based design of peptidomimetic inhibitors of PSD‐95 with improved affinity for the PDZ3 domain
- 3 November 2023
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 598 (2) , 233-241
Abstract
Aberrant brain‐derived neurotrophic factor (BDNF) signaling has been proposed to contribute to the pathophysiology of depression and other neurological disorders such as Angelman syndrome. We have previously shown that targeting the tropomyosin receptor kinase B/postsynaptic density protein‐95 (PSD‐95) nexus in the BDNF signaling pathway by peptidomimetic inhibitors is a promising approach for therapeutic intervention. Here, we used structure‐based knowledge to develop a new Syn3 peptidomimetic compound series that fuses peptides derived from the PSD‐95‐binding protein SynGAP to our prototype compound CN2097. The new compounds target the PSD‐95 PDZ3 domain and adjoining αC helix to achieve bivalent binding that results in up to 7‐fold stronger affinity compared to CN2097. These compounds were designed to improve CN2097 specificity for the PSD‐95 PDZ3 domain, and structure–activity relationship studies were performed to improve their resistance to proteolysis.Keywords
All Related Versions
Funding Information
- Foundation for Angelman Syndrome Therapeutics
- Harrington Discovery Institute, University Hospitals
- National Institute of Mental Health (R21MH104252, R41MH118747)
- National Institute of Neurological Disorders and Stroke (R01NS094440)
This publication has 35 references indexed in Scilit:
- Impairment of TrkB-PSD-95 Signaling in Angelman SyndromePLOS Biology, 2013
- A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damageProceedings of the National Academy of Sciences, 2012
- PDZ domains and their binding partners: structure, specificity, and modificationCell Communication and Signaling, 2010
- A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesiaNeuroscience, 2010
- Hidden dynamic allostery in a PDZ domainProceedings of the National Academy of Sciences, 2009
- A Chemical Library Approach to Organic‐Modified Peptide Ligands for PDZ Domain Proteins: A Synthetic, Thermodynamic and Structural InvestigationChemBioChem, 2008
- A Thermodynamic Ligand Binding Study of the Third PDZ Domain (PDZ3) from the Mammalian Neuronal Protein PSD-95Biochemistry, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Targeting Specific PDZ Domains of PSD-95Chemistry & Biology, 2004
- Thermodynamic profiling of conformationally constrained cyclic ligands for the PDZ domainBioorganic & Medicinal Chemistry Letters, 2004